scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/bmcmi/ManciniGSLMVCPBS13 |
P6179 | Dimensions Publication ID | 1024456207 |
P356 | DOI | 10.1186/1471-2342-13-31 |
P932 | PMC publication ID | 3848463 |
P698 | PubMed publication ID | 24028408 |
P5875 | ResearchGate publication ID | 274348339 |
P50 | author | Arturo Brunetti | Q45394961 |
Raffaele Liuzzi | Q56856579 | ||
Adelaide Greco | Q57613439 | ||
Gennaro Chiappetta | Q89340752 | ||
Rosa Pasquinelli | Q114095731 | ||
Marco Salvatore | Q37370172 | ||
P2093 | author name string | Giuliana Salvatore | |
Marcello Mancini | |||
Gennaro Di Maro | |||
Emilia Vergara | |||
P2860 | cites work | Tumoral angiogenesis and breast cancer | Q37416806 |
Angiogenesis and ovarian cancer. | Q37602374 | ||
Anti-VEGF and beyond: shaping a new generation of anti-angiogenic therapies for cancer | Q37923576 | ||
Molecular genetics and diagnosis of thyroid cancer | Q37924088 | ||
Differentiated thyroid cancers: a comprehensive review of novel targeted therapies | Q37988566 | ||
Relationship between retention of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeted ultrasonographic contrast agent and the level of VEGFR2 expression in an in vivo breast cancer model | Q39979176 | ||
Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects | Q40024036 | ||
Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature | Q40187867 | ||
VEGF-RII influences the prognosis of pancreatic cancer | Q40687210 | ||
Complete inhibition of goiter in mice requires combined gene therapy modification of angiopoietin, vascular endothelial growth factor, and fibroblast growth factor signaling | Q45882684 | ||
Morphological ultrasound microimaging of thyroid in living mice. | Q45933658 | ||
Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model | Q46486160 | ||
[Angiogenesis as part of the tumor "ecosystem" and possibilities to influence it] | Q52598897 | ||
Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: potential markers for aggressive phenotypes. | Q53116192 | ||
[Expression of selected angiogenesis markers and modulators in pre-, peri- and postmenopausal women with ovarian cancer]. | Q53402982 | ||
The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. | Q53403133 | ||
Clinical significance of VEGFR-2 and VEGFR-3 expression in ovarian cancer patients. | Q54589846 | ||
Angiogenesis in Pituitary Adenomas and the Normal Pituitary Gland | Q60586407 | ||
Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density | Q73427365 | ||
Molecular imaging in drug development | Q22122025 | ||
Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides. | Q22255481 | ||
Ultrasound biomicroscopy in small animal research: applications in molecular and preclinical imaging. | Q27025201 | ||
Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis | Q29620559 | ||
Noninvasive ultrasound imaging of inflammation using microbubbles targeted to activated leukocytes | Q30306464 | ||
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. | Q30310994 | ||
Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles | Q30312185 | ||
US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice | Q30431243 | ||
Microbubbles in medical imaging: current applications and future directions | Q30433669 | ||
Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). | Q30474689 | ||
Contrast-enhanced ultrasound for examining tumor biology | Q30493250 | ||
Lessons from mouse models of thyroid cancer | Q33819911 | ||
Guidelines for the welfare and use of animals in cancer research | Q33903753 | ||
Applications for multifrequency ultrasound biomicroscopy in mice from implantation to adulthood. | Q34144707 | ||
Vascular endothelial growth factor: basic science and clinical progress | Q34549887 | ||
Rearrangements of NTRK1 gene in papillary thyroid carcinoma. | Q35010947 | ||
Physiological and pathological angiogenesis in the endocrine system | Q35033876 | ||
A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature | Q35118263 | ||
Molecular diagnosis of tumor angiogenesis and anti-angiogenic cancer therapy | Q35211646 | ||
Angiogenesis in endocrine tumors. | Q35564920 | ||
Anti-VEGF/VEGFR therapy for cancer: reassessing the target | Q35910772 | ||
Molecular ultrasound imaging using a targeted contrast agent for assessing early tumor response to antiangiogenic therapy | Q36297117 | ||
Angiogenesis--a new target for future therapy | Q36424620 | ||
Primary pancreatic lymphomas | Q36473667 | ||
The role of angiogenesis inhibition in the treatment of breast cancer | Q36670444 | ||
Angiogenic growth factors | Q36682043 | ||
VEGF in physiological process and thyroid disease. | Q36996830 | ||
Endoglin in angiogenesis and vascular diseases | Q37088038 | ||
Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. | Q37133833 | ||
alphavbeta3 integrin and angiogenesis: a moody integrin in a changing environment. | Q37220625 | ||
P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | microbubble | Q6839290 |
P921 | main subject | endothelium | Q111140 |
microbubble | Q6839290 | ||
tumor angiogenesis | Q110495869 | ||
P304 | page(s) | 31 | |
P577 | publication date | 2013-09-12 | |
P1433 | published in | BMC Medical Imaging | Q15746685 |
P1476 | title | Imaging of thyroid tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice | |
P478 | volume | 13 |